7.10
0.00
(0.00%)
At close: January 31 at 3:00:00 PM EST
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Assets
9,181,090.00
5,495,948.00
4,805,789.00
3,856,169.00
Total Liabilities Net Minority Interest
4,662,313.00
2,947,934.00
1,525,523.00
405,730.00
Total Equity Gross Minority Interest
4,518,777.00
2,548,014.00
3,280,266.00
3,450,439.00
Total Capitalization
7,269,609.00
4,056,905.00
3,967,789.00
3,364,160.00
Common Stock Equity
4,692,339.00
2,635,627.00
3,164,056.00
3,185,546.00
Capital Lease Obligations
23,119.00
11,852.00
10,091.00
6,566.00
Net Tangible Assets
4,370,425.00
2,475,233.00
3,017,642.00
3,038,878.00
Working Capital
4,472,184.00
1,697,335.00
2,496,561.00
2,831,355.00
Invested Capital
7,660,122.00
4,502,884.00
4,013,387.00
3,377,971.00
Tangible Book Value
4,370,425.00
2,475,233.00
3,017,642.00
3,038,878.00
Total Debt
2,990,902.00
1,879,109.00
859,422.00
198,991.00
Share Issued
841,057.18
841,057.18
817,057.18
787,057.18
Ordinary Shares Number
841,057.18
841,057.18
817,057.18
787,057.18
12/31/2020 - 5/17/2023
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
6855.HK Ascentage Pharma Group International
33.950
-3.00%
ZLDPF Zealand Pharma A/S
101.51
0.00%
AVBP ArriVent BioPharma, Inc.
28.54
-1.89%
NBTX Nanobiotix S.A.
3.4850
-1.83%
CASI CASI Pharmaceuticals, Inc.
2.4750
+1.85%
ONCT Oncternal Therapeutics, Inc.
0.5266
-24.12%
APLM Apollomics, Inc.
8.50
-1.28%
PSTV Plus Therapeutics, Inc.
1.2400
0.00%
ENTO Entero Therapeutics, Inc.
0.4983
-0.32%
LYEL Lyell Immunopharma, Inc.
0.5903
+1.22%